Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-05-10
1978-01-10
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 23259, 424 12, G01N 3300, A61K 4300
Patent
active
040679594
ABSTRACT:
An indirect method for the quantitation of an antigen or antibody in a liquid sample. In the antigen assay, antigen of the same type as the sample antigen is adsorbed onto a solid support surface. Then, specific labelled antibody is immunologically reacted in solution with the sample antigen and the adsorbed antigen. The quantity of reacted labelled antibody on the solid support surface is then determined, as for example, fluorogen label by a fluorometer. The procedure is employed for detection of antibody by reversing the antigen and antibody components in each instance.
REFERENCES:
patent: 3720760 (1973-03-01), Bennich et al.
patent: 3896217 (1975-07-01), Johnson
patent: 3940475 (1976-02-01), Gross
Crosignani et al., Journal of Clinical Endocrinology and Metabolism, vol. 30, No. 2, Feb., 1970, pp. 153-160.
Miles et al., Analytical Biochemistry, vol. 61, No. 1 Sept., 1974, pp. 209-224.
Catt, Acta Endocrinologica Supplementum, No. 142, 1969, pp. 222-246.
International Diagnostic Technology, Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Indirect solid surface test for antigens or antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indirect solid surface test for antigens or antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indirect solid surface test for antigens or antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2271321